Pharmacokinetics, Safety, and Tolerability Study of GOPRELTO® Nasal Solution
Status:
Not yet recruiting
Trial end date:
2021-12-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to assess the pharmacokinetic (PK) properties, safety,
tolerability, and dosing of GOPRELTO® as an anesthetic for diagnostic procedures and
surgeries on or through the mucous membranes of the nasal cavities in pediatric adolescent
subjects.